Skip to main content
TipRanks
Go Ultimate75% OFF

ImmunityBio (IBRX) Q1 2026 Earnings Report

2,638 Followers

IBRX Q1 2026 EPS Results

Actual EPS
-$0.62
Consensus EPS
-$0.07
Beat/Miss
Missed by -$0.55
One Year Ago EPS
-$0.15

IBRX Q1 2026 Revenue Results

Actual Revenue
$44.21M
Expected Revenue
$43.07M
Beat/Miss
Beat by +$1.14M
YoY Revenue Growth
+167.64%

Earnings Announcement Details

Quarter
Q1 2026
Date
05/07/2026
Time
Before Open
Conference Call
Thursday, May 7, 2026
IBRX Upcoming Earnings

ImmunityBio's next earnings date is estimated for March 2, 2027, based on past reporting schedules.

Q1 2026 Earnings Call Audio

No earnings call audio is available for this earnings event.

Q1 2026 Earnings Slide Deck

No slide deck is available for this earnings event.

Q1 2026 Earnings Call Summary

No earnings call summary is available for this earnings event.

IBRX Earnings History

IBRX earnings history
Report DateFiscal QuarterForecast / EPSLast Year's EPSEPS YoY ChangePress Release
Mar 02, 20272026 (Q4)-0.14--0.06――
Nov 09, 20262026 (Q3)-0.07-0.18-0.07-157.14% (-0.11)
Aug 04, 20262026 (Q2)-0.08-0.22-0.1-120.00% (-0.12)
May 07, 20262026 (Q1)-0.07-0.62-0.15-313.33% (-0.47)
Mar 03, 20262025 (Q4)-0.08-0.06-0.0933.33% (+0.03)
Nov 04, 20252025 (Q3)-0.11-0.07-0.1450.00% (+0.07)
Aug 05, 20252025 (Q2)-0.11-0.10-0.250.00% (+0.10)
May 12, 20252025 (Q1)-0.13-0.15-0.225.00% (+0.05)
Mar 03, 20252024 (Q4)-0.20-0.09-0.3675.00% (+0.27)
Nov 12, 20242024 (Q3)-0.18-0.14-0.1926.32% (+0.05)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat Missed